Matinas BioPharma (MTNB) Looks Good: Stock Adds 8.6% in Session

Matinas BioPharma Holdings, Inc.


was a big mover last session, as the company saw its shares rise nearly 9% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of 76-89 cents per share in the past one-month time frame.

The company has seen one positive estimate revision in the past month, while its Zacks Consensus Estimate for the current quarter has also moved higher in the same time frame, suggesting that more solid trading could be ahead for Matinas BioPharma. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.

Matinas BioPharma currently has a Zacks Rank #3 (Hold) while its

Earnings ESP

is positive.

Matinas BioPharma Holdings, Inc. Price

Matinas Biopharma Holdings, Inc. Price

Matinas BioPharma Holdings, Inc. price


Matinas BioPharma Holdings, Inc. Quote

A better-ranked stock in the Medical – Drugs industry is

Ironwood Pharmaceuticals, Inc.


, which currently carries a Zacks Rank #2 (Buy). You can see

the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here


Looking for Stocks with Skyrocketing Upside?

Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.

Ignited by referendums and legislation, this industry is expected to blast from an already robust $17.7 billion in 2019 to a staggering $73.6 billion by 2027. Early investors stand to make a killing, but you have to be ready to act and know just where to look.

See the pot stocks we’re targeting >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.

Click to get this free report

To read this article on click here.

Zacks Investment Research

If You Liked This Article Click To Share